Jiazhuo Liu

机构：Dalian Medical University, Sichuan University, West China Hospital of Sichuan University, Dalian University · ORCID：0000-0001-6238-4589

发表论文 19 篇 · 总被引 268 次 · h-index 8

代表论文

Nivolumab treatment of relapsed/refractory Epstein-Barr virus–associated hemophagocytic lymphohistiocytosis in adults (2020 · Blood · 被引 140)
SECTM1-based CAR T cells enriched with CD7-low/negative subsets exhibit efficacy in CD7-positive malignancies (2023 · Blood Advances · 被引 28)
A new conditioning regimen with chidamide, cladribine, gemcitabine and busulfan significantly improve the outcome of high‐risk or relapsed/refractory non‐Hodgkin 's lymphomas (2021 · International Journal of Cancer · 被引 23)
Intensive induction chemotherapy with regimen containing intermediate dose cytarabine in the treatment of de novo acute myeloid leukemia (2009 · American Journal of Hematology · 被引 21)
Myelomonocytic and monocytic acute myeloid leukemia demonstrate comparable poor outcomes with venetoclax-based treatment: a monocentric real-world study (2024 · Annals of Hematology · 被引 17)
Combining azole antifungals with venetoclax plus azacitidine in patients with newly diagnosed acute myeloid leukemia (2024 · Hematology · 被引 9)